Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penehyclidine hydrochloride for microcirculatory dysfunction in septic shock
ChiCTR2500102046Phase 4Not yet recruiting
- Sponsor
- Hunan Provincial People's Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of penehyclidine in septic shock (2 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Peripheral perfusion index, Capillary refill time and 1 more. Planned start May 2025; status: not yet recruiting.
02
Drugs
penehyclidine
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR2500102046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102046.